Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-08-16 Purchase | 2021-08-17 4:11 pm | DiaMedica Therapeutics Inc. | DMAC | Burroughs Amy L. Director | 44,950 | $3.15 | $141,593 | 44,950 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-01 Option Award | 2024-03-05 6:01 pm | N/A N/A | Terns Pharmaceuticals Inc. | TERN | Burroughs Amy L. Chief Executive Officer | 1,400,000 | $0 | 1,400,000 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-12 8:09 pm | 2024-06-09 2033-06-08 | Tenaya Therapeutics Inc. | TNYA | Burroughs Amy L. Director | 14,766 | $0 | 14,766 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-03 4:36 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Burroughs Amy L. Director | 17,156 | $1.53 | 73,288 (Direct) | View |
| 2022-12-05 Option Award | 2022-12-07 6:20 pm | 2023-01-05 2032-12-04 | Tenaya Therapeutics Inc. | TNYA | Burroughs Amy L. Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-02 4:58 pm | N/A 2032-05-31 | DiaMedica Therapeutics Inc. | DMAC | Burroughs Amy L. Director | 13,222 | $0 | 69,354 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-03 4:39 pm | N/A N/A | DiaMedica Therapeutics Inc. | DMAC | Burroughs Amy L. Director | 11,182 | $3.58 | 56,132 (Direct) | View |
| 2021-07-15 Option Award | 2021-07-16 4:35 pm | N/A 2031-07-14 | DiaMedica Therapeutics Inc. | DMAC | Burroughs Amy L. Director | 18,786 | $0 | 18,786 (Direct) | View |